Rankings
▼
Calendar
SCLX Q4 2020 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$73M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$6M
+12.0% YoY
Gross Profit
$5M
90.9% margin
Operating Income
-$9M
-149.7% margin
Net Income
-$12M
-201.7% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$199,484
Total Liabilities
$180,760
Stockholders' Equity
$18,724
Cash & Equivalents
$30,510
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$5M
+12.0%
Gross Profit
$5M
$4M
+40.6%
Operating Income
-$9M
-$35M
+74.6%
Net Income
-$12M
-$45M
+73.4%
← FY 2020
All Quarters
Q1 2021 →